By Year : Latest  |  All  |   2025  |  2024  |  2023  |  2022  |  2021  |  2020  |  2019  |  2018  |  2017  |  2016  |  2015  |  2014  |  2013  |  2012

< Previous Page  |  Next Page >

• 09 Dec 2015
  
  Increase In Shareholding In StemLife Berhad
• 09 Dec 2015
  
  Increase In Shareholding In StemLife Berhad
• 07 Dec 2015
  
  Offer Declared Unconditional
• 04 Dec 2015
  
  Increase In Shareholding In StemLife Berhad
• 03 Dec 2015
  
  Reconstitution Of Nominating Committee Of The Company
• 03 Dec 2015
  
  Increase In Shareholding In StemLife Berhad
• 03 Dec 2015
  
  Conditional Take-Over Offer To Acquire All The Remaining Ordinary Shares In StemLife Berhad Not Already Owned By Cordlife Group Limited - Despatch Of Offer Document
• 03 Dec 2015
  
  Disclosure Of Interest/ Changes In Interest Of Substantial Shareholder(s)/ Unitholder(s) - Change In Substantial Shareholder's Interest
• 30 Nov 2015
  
  Resignation Of Company Secretary
• 30 Nov 2015
  
  Notification Of Substantial Shareholder's Interest
• 27 Nov 2015
  
  Disclosure Of Interest/ Changes In Interest Of Substantial Shareholder(s)/ Unitholder(s) - Disclosure Of Substantial Shareholder's Interest
• 27 Nov 2015
  
  Disclosure Of Interest/ Changes In Interest Of Substantial Shareholder(s)/ Unitholder(s) - Disclosure Of Substantial Shareholder's Interest
• 25 Nov 2015
  
  Reply To SGX-ST Query Regarding Trading Activity
• 17 Nov 2015
  
  Disclosure Of Interest/ Changes In Interest Of Director/ Chief Executive Officer - Change Of Director's Interest
• 16 Nov 2015
  
  1QFY2016 Results Presentation
• 13 Nov 2015
  
  Notice Of Book Closure Date For Special Interim Dividend
• 13 Nov 2015
  
  Cordlife's 1QFY2016 Core Net Profit Before Income Tax From Operations Grows 4.5% To S$1.8 Million
• 13 Nov 2015
  
  Financial Statements And Related Announcement - First Quarter Results
• 13 Nov 2015
  
  Completion Of The Disposal Of A 7% Senior Unsecured Convertible Note Due 2017 Issued By China Cord Blood Corporation To The Company
• 12 Nov 2015
  
  Cordlife Increases Its Interest In Malaysia Listed Stem Cell Banking Company StemLife Berhad To 33.03% And Extends Conditional Mandatory Take-Over Offer For Remaining Shares

< Previous Page  |  Next Page >